Mandibular advancement devices and sleep disordered breathing.

Sleep Med Rev

UCLA School of Dentistry, Section of Orofacial Pain and Oral Medicine, Center for the Health Sciences, 90095-1668, USA.

Published: August 1998

It has been nearly 90 years since a dentist first fabricated a dental appliance for a patient with snoring. Since then, mandibular advancement devices or MADs have become a common treatment for obstructive sleep apnea and are used to increase the caliber of the airway during sleep. Their primary use is for the patient who has snoring or mild to moderate, but not severe, OSA problems. Unfortunately, only a small amount of empirical data exists on the topics of long-term compliance, complications and contraindications for these devices. Nevertheless, it appears that only a small percentage of patients will quit using a MAD because of temporomandibular joint (TMJ) or masticatory muscle soreness. An even smaller percent of the long-term MAD users will get changes in their occlusion. Compliance reports suggest that only 50% of the patients will be using the device after 3 years. Overall, these data suggest that MADs should be carefully fabricated by dentists who work on a referral basis with sleep medicine physicians and patients using MADs must be monitored regularly for ongoing efficacy and for associated complications. The good news (with good data support for this conclusion) is that MAD's are a moderately effective treatment of snoring and mild to moderate OSA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1087-0792(98)90019-3DOI Listing

Publication Analysis

Top Keywords

mandibular advancement
8
advancement devices
8
patient snoring
8
snoring mild
8
mild moderate
8
patients will
8
sleep
4
devices sleep
4
sleep disordered
4
disordered breathing
4

Similar Publications

Beyond the mouth: An overview of obstructive sleep apnea in adults for dentists.

J Prosthodont

January 2025

Sleep Life Med, Ewa Beach, HI and Los Alamitos, California, USA.

Obstructive sleep apnea (OSA) is a common and complex medical sleep condition in adults that is associated with chronic medical and mental health conditions. Left undiagnosed and untreated it can decrease quality of life and increase morbidity and mortality. Dentists are at the forefront for screening OSA in their role to maintain the health of the oral cavity.

View Article and Find Full Text PDF

Background: Establishing accurate, reliable, and convenient methods for enamel segmentation and analysis is crucial for effectively planning endodontic, orthodontic, and restorative treatments, as well as exploring the evolutionary patterns of mammals. However, no mature, non-destructive method currently exists in clinical dentistry to quickly, accurately, and comprehensively assess the integrity and thickness of enamel chair-side. This study aims to develop a deep learning work, 2.

View Article and Find Full Text PDF

Objectives: This non-randomised clinical study aimed to identify the phenotypic characteristics that distinguish responders from non-responders. Additionally, it sought to establish a predictive model for treatment response to obstructive sleep apnoea (OSA) using mandibular advancement devices (MAD), based on the analysed phenotypic characteristics.

Material And Methods: This study, registered under identifier NCT05596825, prospectively analysed MAD treatment over 6 years using two-piece adjustable appliances according to a standardised protocol.

View Article and Find Full Text PDF

Aim: This review aims to explore the clinical applications, biological mechanisms, and potential benefits of concentrated growth factors (CGFs), autologous materials, and xenografts in bone regeneration, particularly in dental treatments such as alveolar ridge preservation, mandibular osteonecrosis, and peri-implantitis.

Materials And Methods: A systematic literature search was conducted using databases like PubMed, Scopus, and Web of Science, with keywords such as "bone regeneration" and "CGF" from 2014 to 2024. Only English-language clinical studies involving human subjects were included.

View Article and Find Full Text PDF

Beta-tricalcium phosphate patient-specific gap implants in bilateral sagittal split osteotomy: an innovative treatment method to enhance the mandibular border contour. Part 1: concept and workflow.

Int J Oral Maxillofac Surg

January 2025

Division of Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge AV, Bruges, Belgium; Oral and Maxillofacial Surgery Unit, Division of Surgery, Barzilai Medical Center, Affiliated to Ben-Gurion University of the Negev, Ashkelon, Israel.

Antegonial notching can occur after bilateral sagittal split osteotomy (BSSO) and may lead to unpleasant aesthetic outcomes in both young and older patients. This clinical study presents a new concept to potentially overcome this problem and describes the workflow. Beta-tricalcium phosphate patient-specific gap implants (β-TCP gap-PSIs) are biocompatible and resorbable bone grafts that are placed in the space of the osteotomy gap during orthognathic procedures; they are virtually planned and printed in 3D.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!